{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:52:39Z","timestamp":1791049959746,"version":"4.1.0"},"reference-count":96,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":401,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jacc.2022.07.013","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T14:39:50Z","timestamp":1662388790000},"page":"1268-1283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other\u00a0Inherited Cardiovascular Diseases"],"prefix":"10.1016","volume":"80","author":[{"given":"Christopher","family":"Semsarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina H.","family":"Haugaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lampert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Kovacic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2022.07.013_bib1","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2003.03.002","article-title":"Does sports activity enhance the risk of sudden death in adolescents and young adults?","volume":"42","author":"Corrado","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1714719","article-title":"Outcomes of cardiac screening in adolescent soccer players","volume":"379","author":"Malhotra","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib3","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A\u00a0prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCULATIONAHA.115.015431","article-title":"Incidence, cause, and comparative frequency of sudden cardiac death in National Collegiate Athletic Association athletes: a decade in review","volume":"132","author":"Harmon","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.07.013_bib5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.mayocp.2016.07.021","article-title":"Incidence and etiology of sudden cardiac arrest and death in high school athletes in the United States","volume":"91","author":"Harmon","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jacc.2022.07.013_bib6","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.jacc.2017.01.015","article-title":"international recommendations for electrocardiographic interpretation in athletes","volume":"69","author":"Sharma","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.csm.2015.03.008","article-title":"The electrocardiogram in highly trained athletes","volume":"34","author":"Prakash","year":"2015","journal-title":"Clin Sports Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/clc.23289","article-title":"Utility of genetic testing in athletes","volume":"43","author":"Gray","year":"2020","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib9","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/CIRCULATIONAHA.112.000270","article-title":"Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin","volume":"127","author":"Zaidi","year":"2013","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jacc.2022.07.013_bib10","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jcmg.2018.09.021","article-title":"Cardiac magnetic resonance normal reference values of biventricular size and function in male athlete's heart","volume":"12","author":"D'Ascenzi","year":"2019","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2022.07.013_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib12","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/eurheartj\/ehv110","article-title":"Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Ruwald","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.07.013_bib13","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/eurheartj\/ehv202","article-title":"Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes","volume":"36","author":"La Gerche","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.07.013_bib14","article-title":"Endomyocardial biopsy: the forgotten piece in the arrhythmogenic cardiomyopathy puzzle","volume":"10","author":"Casella","year":"2021","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacc.2022.07.013_bib15","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.hrthm.2021.09.013","article-title":"Ventricular arrhythmias in athletes: role of a comprehensive diagnostic workup","volume":"19","author":"Dello Russo","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2022.07.013_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2143\/AC.60.4.2004987","article-title":"QT dispersion and\u00a0left ventricular hypertrophy in athletes: relationship with angiotensin-converting enzyme I\/D polymorphism","volume":"60","author":"Tanriverdi","year":"2005","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib17","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1161\/CIRCULATIONAHA.120.048916","article-title":"Exercise training-induced repolarization abnormalities masquerading as congenital long QT syndrome","volume":"142","author":"Dagradi","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.07.013_bib18","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","article-title":"Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006","volume":"119","author":"Maron","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.07.013_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1941738118799084","article-title":"survival after exercise-related sudden cardiac arrest in young athletes: can we do better?","volume":"11","author":"Drezner","year":"2019","journal-title":"Sports Health"},{"issue":"25","key":"10.1016\/j.jacc.2022.07.013_bib20","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib21","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A\u00a0novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O'Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.07.013_bib22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0735-1097(94)90844-3","article-title":"26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse","volume":"24","author":"Maron","year":"1994","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib23","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2005.02.006","article-title":"Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities-general considerations","volume":"45","author":"Maron","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib24","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/eurheartj\/ehi325","volume":"26","author":"Pelliccia","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.07.013_bib25","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.jacc.2015.09.035","volume":"66","author":"Maron","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.amjcard.2012.12.018","article-title":"Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy","volume":"111","author":"Reineck","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2016-000484","article-title":"Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers","volume":"3","author":"Sweeting","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.jacc.2022.07.013_bib28","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacc.2013.03.062","article-title":"Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy","volume":"62","author":"Olivotto","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamacardio.2019.4268","article-title":"Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy","volume":"5","author":"Fumagalli","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib30","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1161\/01.CIR.0000097110.55312.BF","article-title":"Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease","volume":"108","author":"Sorajja","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.07.013_bib31","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.amjcard.2012.01.363","article-title":"Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"109","author":"Sorajja","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jcmg.2013.08.010","article-title":"Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes","volume":"7","author":"Desai","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2022.07.013_bib33","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1161\/01.RES.0000205766.97556.00","article-title":"Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy","volume":"98","author":"Konhilas","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2022.07.013_bib34","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2017.2503","article-title":"Effect of moderate-intensity exercise training on peak oxygen consumption in patients with hypertrophic cardiomyopathy: a randomized clinical trial","volume":"317","author":"Saberi","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2022.07.013_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/2047487313501277","article-title":"Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center","volume":"22","author":"Klempfner","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib36","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/bjsports-2020-101987","article-title":"Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): more physical activity is better","volume":"55","author":"Kwon","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib37","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0002-9149(84)91437-1","article-title":"Hypertrophic cardiomyopathy compatible with successful completion of the marathon","volume":"53","author":"Maron","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib38","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.003454","article-title":"clinical profile of athletes with hypertrophic cardiomyopathy","volume":"8","author":"Sheikh","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2022.07.013_bib39","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/bjsports-2019-100890","article-title":"Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study","volume":"54","author":"Pelliccia","year":"2020","journal-title":"Br J Sports Med"},{"issue":"1","key":"10.1016\/j.jacc.2022.07.013_bib40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcmg.2021.08.012","article-title":"Neither athletic training nor detraining affects LV hypertrophy in adult, low-risk patients with HCM","volume":"15","author":"Pelliccia","year":"2022","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jacc.2022.07.013_bib41","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.112.000447","article-title":"Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry","volume":"127","author":"Lampert","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.07.013_bib42","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.117.027828","article-title":"Safety of sports for athletes with implantable cardioverter-defibrillators: long-term results of a prospective multinational registry","volume":"135","author":"Lampert","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.07.013_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.jacc.2022.07.013_bib44","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1016\/j.jacc.2020.08.044","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"76","author":"Ommen","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib45","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bjsports-2020-102921","article-title":"Return to play with hypertrophic cardiomyopathy: are we moving too fast? A critical review","volume":"55","author":"Drezner","year":"2021","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib46","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jacc.2014.01.041","article-title":"Incidence and causes of sudden death in U.S. college athletes","volume":"63","author":"Maron","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib47","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1016\/j.jacc.2020.12.073","article-title":"Precision medicine in catecholaminergic polymorphic ventricular tachycardia: JACC focus seminar 5\/5","volume":"77","author":"Priori","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib48","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.jacc.2021.03.325","article-title":"precision medicine approaches to cardiac arrhythmias: JACC focus seminar 4\/5","volume":"77","author":"Giudicessi","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib49","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2020.12.072","article-title":"Contemporary and future approaches to precision medicine in inherited cardiomyopathies: JACC focus seminar 3\/5","volume":"77","author":"Fatkin","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib50","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1016\/j.jacc.2021.04.001","article-title":"Precision medicine approaches to vascular disease: JACC focus seminar 2\/5","volume":"77","author":"Miller","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib51","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.jacc.2020.12.071","article-title":"Precision medicine in cardiovascular disease: genetics and impact on phenotypes: JACC focus seminar 1\/5","volume":"77","author":"Semsarian","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/eurheartj\/ehy730","article-title":"Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)","volume":"40","author":"Pelliccia","year":"2019","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jacc.2022.07.013_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.116.001620","article-title":"Nonfamilial hypertrophic cardiomyopathy: prevalence, natural history, and clinical implications","volume":"10","author":"Ingles","year":"2017","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jacc.2022.07.013_bib54","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.07.013_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2022.07.013_bib56","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41588-020-00762-2","article-title":"Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect","volume":"53","author":"Tadros","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacc.2022.07.013_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib58","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","article-title":"T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jacc.2022.07.013_bib59","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2017.07.015","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"250","author":"Dejgaard","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib60","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1249\/MSS.0000000000002015","article-title":"Association between lifelong physical activity and disease characteristics in HCM","volume":"51","author":"Aengevaeren","year":"2019","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jacc.2022.07.013_bib61","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1161\/CIRCULATIONAHA.118.037230","article-title":"Sudden death and left ventricular involvement in arrhythmogenic cardiomyopathy","volume":"139","author":"Miles","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2022.07.013_bib62","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib63","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ejhf.181","article-title":"Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members","volume":"16","author":"Saberniak","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jacc.2022.07.013_bib64","first-page":"744","article-title":"Harmful effects of exercise intensity and exercise duration in patients with arrhythmogenic cardiomyopathy","volume":"4","author":"Lie","year":"2018","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2022.07.013_bib65","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A\u00a0new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.07.013_bib66","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/europace\/euab077","article-title":"Sex differences in disease progression and arrhythmic risk in patients with arrhythmogenic cardiomyopathy","volume":"23","author":"Rootwelt-Norberg","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2022.07.013_bib67","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.hrthm.2020.03.020","article-title":"Exercise and detraining are modifiable factors for arrhythmic risk in arrhythmogenic cardiomyopathy needing correct dosage","volume":"17","author":"Haugaa","year":"2020","journal-title":"Heart Rhythm"},{"issue":"14","key":"10.1016\/j.jacc.2022.07.013_bib68","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/eurheartj\/ehz570","article-title":"High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy","volume":"41","author":"Chivulescu","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.07.013_bib69","doi-asserted-by":"crossref","first-page":"9819","DOI":"10.1038\/s41598-020-66656-9","article-title":"The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy","volume":"10","author":"Eijgenraam","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacc.2022.07.013_bib70","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers\u2013reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2022.07.013_bib71","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jacc.2008.06.044","article-title":"Long-term outcome and risk stratification in dilated cardiolaminopathies","volume":"52","author":"Pasotti","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib72","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jacc.2011.08.078","article-title":"Risk factors for malignant ventricular arrhythmias in lamin a\/c mutation carriers a European cohort study","volume":"59","author":"van Rijsingen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib73","article-title":"Exercise is associated with impaired left ventricular systolic function in patients with Lamin A\/C genotype","volume":"9","author":"Skj\u00f8lsvik","year":"2020","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2022.07.013_bib74","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/bjsports-2012-091751","article-title":"Return to play? Athletes with congenital long QT syndrome","volume":"47","author":"Johnson","year":"2013","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib75","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2018.01.078","article-title":"Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome","volume":"71","author":"Mazzanti","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib76","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib77","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2021.04.026","article-title":"Return-to-play for athletes with long QT syndrome or genetic heart diseases predisposing to sudden death","volume":"78","author":"Tobert","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib78","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacc.2022.07.013_bib79","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/europace\/eup448","article-title":"High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening","volume":"12","author":"Haugaa","year":"2010","journal-title":"Europace"},{"key":"10.1016\/j.jacc.2022.07.013_bib80","first-page":"253","article-title":"Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia: a single center's early experience","volume":"2","author":"Ostby","year":"2016","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jacc.2022.07.013_bib81","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.amjcard.2014.03.012","article-title":"Effects of individualized exercise training in patients with catecholaminergic polymorphic ventricular tachycardia type 1","volume":"113","author":"Manotheepan","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib82","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1249\/JSR.0000000000000575","article-title":"Shared decision making for athletes with cardiovascular disease: practical considerations","volume":"18","author":"Baggish","year":"2019","journal-title":"Curr Sports Med Rep"},{"key":"10.1016\/j.jacc.2022.07.013_bib83","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1177\/03635465010290062201","article-title":"Quality of life assessment in elite collegiate athletes","volume":"29","author":"McAllister","year":"2001","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib84","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1540-8159.2011.03229.x","article-title":"Adolescents with implantable cardioverter defibrillators: a patient and parent perspective","volume":"35","author":"Rahman","year":"2012","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib85","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjsports-2015-095560","article-title":"The impact of diagnosis: measuring the psychological response to being diagnosed with serious or potentially lethal cardiac disease in young competitive athletes","volume":"50","author":"Asif","year":"2016","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib86","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.hroo.2022.01.009","article-title":"Experiences of athletes with arrhythmogenic cardiac conditions in returning to play","volume":"3","author":"Shapero","year":"2022","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.jacc.2022.07.013_bib87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1540-8167.2005.00331.x","article-title":"Safety of sports participation in patients with implantable cardioverter-defibrillators: a survey of Heart Rhythm Society Members","volume":"17","author":"Lampert","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib88","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1001\/jama.2012.9334","article-title":"Competitive sports participation in athletes with congenital long QT syndrome","volume":"308","author":"Johnson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2022.07.013_bib89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev-med-041316-090402","article-title":"Updated recommendations for athletes with heart disease","volume":"69","author":"Lampert","year":"2018","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib90","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1056\/NEJMp1109283","article-title":"Shared decision making\u2014the pinnacle of patient-centered care","volume":"366","author":"Barry","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib91","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrcardio.2017.6","article-title":"Shared decision-making in HCM","volume":"14","author":"Maron","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2022.07.013_bib92","series-title":"Northwestern University","author":"Knapp","year":"1996"},{"key":"10.1016\/j.jacc.2022.07.013_bib93","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJM199811263392211","article-title":"Competitive athletes with cardiovascular disease--the case of Nicholas Knapp","volume":"339","author":"Maron","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib94","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1056\/NEJMp1510020","article-title":"Shared decision making\u2014finding the sweet spot","volume":"374","author":"Fried","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2022.07.013_bib95","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4085\/j.jacc.2016.03.527","article-title":"Interassociation consensus statement on cardiovascular care of college student-athletes","volume":"51","author":"Hainline","year":"2016","journal-title":"J\u00a0Athl Train"},{"key":"10.1016\/j.jacc.2022.07.013_bib96","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.hrthm.2018.10.032","article-title":"Competitive athletes with implantable cardioverter defibrillators: how to program? Data from the Implantable Cardioverter Defibrillator Sports Registry","volume":"16","author":"Olshansky","year":"2019","journal-title":"Heart Rhythm"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722056637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109722056637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:51:06Z","timestamp":1760017866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109722056637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":96,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0735109722056637"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2022.07.013","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Athletic Activity for Patients With Hypertrophic Cardiomyopathy and Other\u00a0Inherited Cardiovascular Diseases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2022.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}